MedTrace Logo

Early Neuroprognostication After OHCA

NCT05706194 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-03-21

No results posted yet for this study

Summary

This is a prospective observational substudy of the STEPCARE trial ClinicalTrials.gov Identifier: NCT05564754) with the aim to examine whether prognostication of neurological outcome after cardiac arrest can be performed earlier than the 72 h time-point recommended by guidelines today.

Conditions

  • Cardiac Arrest
  • Neurological Outcome
  • EEG
  • CT
  • Brain Injuries
  • Biomarkers

Interventions

DIAGNOSTIC_TEST

Early neurological prognostication with biomarkers, EEG and CT

Biomarker samples collected at 12, 24, 48 and 72 h after randomisation, CT and EEG performed as early as possible after 24 h post randomisation in patients still unconscious (defined as not awake and able to follow verbal commands)

Sponsors & Collaborators

  • Helsingborgs Hospital

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Skane University Hospital

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Lund University

    lead OTHER

Principal Investigators

  • Niklas Nielsen, MD, PhD · Lund University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2027-12-31
Completion
2029-07-31

Countries

  • Finland
  • Germany
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05706194 on ClinicalTrials.gov